J G Gribben1, L M Nadler. Show Affiliations » 1. Harvard Medical School, Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, Massachusetts.
Abstract
Entities: Disease Species
Mesh： See more » Antineoplastic Agents/therapeutic useBone Marrow PurgingBone Marrow TransplantationChromosomes, Human, Pair 14/ultrastructureChromosomes, Human, Pair 18/ultrastructureDNA, Neoplasm/analysisGene Rearrangement, B-LymphocyteGenes, ImmunoglobulinHumansImmunoglobulin Heavy Chains/geneticsLife TablesLymphoma, Non-Hodgkin/diagnosisLymphoma, Non-Hodgkin/drug therapyLymphoma, Non-Hodgkin/pathologyLymphoma, Non-Hodgkin/surgeryNeoplastic Cells, CirculatingPolymerase Chain ReactionPrognosisProto-Oncogene Proteins/geneticsProto-Oncogene Proteins c-bcl-2Proto-OncogenesTranslocation, GeneticTreatment Outcome
Substances： See more » Antineoplastic AgentsDNA, NeoplasmImmunoglobulin Heavy ChainsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2
Year: 1994 PMID： 8206485
Source DB: PubMed Journal: Important Adv Oncol ISSN： 0883-5896